新闻发布 | AG尊龙集团中文官方网站
尊龙凯时 - 人生就是搏!
AG尊龙
跳转到主要内容
搜索
Site Search
Mainland China
|
zh
Choose locations
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
Español
(link is external)
Brazil |
Português
(link is external)
Canada |
English
(link is external)
Canada |
Français
(link is external)
Central America |
Español
(link is external)
Colombia |
Español
(link is external)
Mexico |
Español
(link is external)
United States |
English
(link is external)
Australia |
English
(link is external)
Bangladesh |
English
(link is external)
Hong Kong S.A.R. |
繁體中文
(link is external)
India |
English
(link is external)
Indonesia |
English
(link is external)
Japan |
日本語
(link is external)
Korea |
한국어
(link is external)
Mainland China |
中文
Malaysia |
English
(link is external)
Pakistan |
English
(link is external)
Philippines |
English
(link is external)
Singapore |
English
(link is external)
Taiwan |
繁體中文
(link is external)
Thailand |
ภาษาไทย
(link is external)
Austria |
Deutsch
(link is external)
Belgium |
Français
(link is external)
Belgium |
Nederlands
(link is external)
Bulgaria |
Български
(link is external)
Czech Republic |
Česky
(link is external)
Czech Republic |
English
(link is external)
Denmark |
Dansk
(link is external)
Estonia |
Eesti
(link is external)
Finland |
Suomalainen
(link is external)
France |
Français
(link is external)
Germany |
Deutsch
(link is external)
Greece |
Ελληνικά
(link is external)
Hungary |
Magyar
(link is external)
Ireland |
English
(link is external)
Italy |
Italiano
(link is external)
Latvia |
Latvian
(link is external)
Lithuania |
Lithuanian
(link is external)
Netherlands |
Nederlands
(link is external)
Norway |
Norsk
(link is external)
Poland |
Polski
(link is external)
Portugal |
Português
(link is external)
Romania |
Română
(link is external)
Russia |
Русский
(link is external)
Serbia |
Srpski
(link is external)
Slovakia |
Slovensky
(link is external)
Slovenia |
Slovenščina
(link is external)
Slovenia |
English
(link is external)
Spain |
Español
(link is external)
Sweden |
Svenska
(link is external)
Switzerland |
Deutsch
(link is external)
Switzerland |
Français
(link is external)
Turkey |
Türk
(link is external)
United Kingdom |
English
(link is external)
Global |
English
(link is external)
Novartis Foundation |
English
(link is external)
Egypt |
English
(link is external)
Israel |
עברית
(link is external)
Saudi Arabia |
العربية
(link is external)
South Africa |
English
(link is external)
cn
Choose locations
asia-pacific
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
Español
(link is external)
Australia |
English
(link is external)
Austria |
Deutsch
(link is external)
Bangladesh |
English
(link is external)
Belgium |
Français
(link is external)
Belgium |
Nederlands
(link is external)
Brazil |
Português
(link is external)
Bulgaria |
Български
(link is external)
Canada |
English
(link is external)
Canada |
Français
(link is external)
Central America |
Español
(link is external)
Colombia |
Español
(link is external)
Czech Republic |
Česky
(link is external)
Czech Republic |
English
(link is external)
Denmark |
Dansk
(link is external)
Egypt |
English
(link is external)
Estonia |
Eesti
(link is external)
Finland |
Suomalainen
(link is external)
France |
Français
(link is external)
Germany |
Deutsch
(link is external)
Greece |
Ελληνικά
(link is external)
Hong Kong S.A.R. |
繁體中文
(link is external)
Hungary |
Magyar
(link is external)
India |
English
(link is external)
Indonesia |
English
(link is external)
Ireland |
English
(link is external)
Israel |
עברית
(link is external)
Italy |
Italiano
(link is external)
Japan |
日本語
(link is external)
Korea |
한국어
(link is external)
Latvia |
Latvian
(link is external)
Lithuania |
Lithuanian
(link is external)
Mainland China |
中文
Malaysia |
English
(link is external)
Mexico |
Español
(link is external)
Netherlands |
Nederlands
(link is external)
Norway |
Norsk
(link is external)
Global |
English
(link is external)
Novartis Foundation |
English
(link is external)
Pakistan |
English
(link is external)
Philippines |
English
(link is external)
Poland |
Polski
(link is external)
Portugal |
Português
(link is external)
Romania |
Română
(link is external)
Russia |
Русский
(link is external)
Saudi Arabia |
العربية
(link is external)
Serbia |
Srpski
(link is external)
Singapore |
English
(link is external)
Slovakia |
Slovensky
(link is external)
Slovenia |
Slovenščina
(link is external)
Slovenia |
English
(link is external)
South Africa |
English
(link is external)
Spain |
Español
(link is external)
Sweden |
Svenska
(link is external)
Switzerland |
Deutsch
(link is external)
Switzerland |
Français
(link is external)
Taiwan |
繁體中文
(link is external)
Thailand |
ภาษาไทย
(link is external)
Turkey |
Türk
(link is external)
United Kingdom |
English
(link is external)
United States |
English
(link is external)
菜单
关于AG尊龙
战略
多元、平等与包容
员工和文化
我们的价值观
我们的领导层
AG尊龙
关于AG尊龙
患者与照护者
AG尊龙对患者和照护者的承诺
疾病领域
临床试验
患者与照护者
AG尊龙在中国
概览
企业责任
AG尊龙大事记
AG尊龙中国业务
AG尊龙中国荣誉
AG尊龙在中国
环境、社会和治理
道德、风险和合规
可及性
环境可持续发展
全球健康
道德行为
环境、社会和治理
新闻中心
新闻发布
专题故事
媒体联络
新闻中心
职业发展
职位搜索
人才发展
员工福利
全球荣誉
(link is external)
职业发展
首页
页眉
AG尊龙上海园区
扎根中国，承诺中华
主页
新闻中心
新闻发布
新闻发布
Date Range
- 任意 -
In The News
Media Release
Featured News
Story
News Type Filters
Language
- 任意 -
English
French
German
开始日期
结束日期
News Archive Navigation
News Archive Navigation
全部
新闻发布
专题故事
icon
列表视图
Showing 245 results
6月 2021
Featured News
6月 04, 2021
《沙库巴曲缬沙坦钠共晶物药学特性专家共识》在京发布 指导心衰治疗规范用药
Featured News
6月 03, 2021
诺欣妥®获批高血压适应症 突破10年来高血压无新药困境
五月 2021
Featured News
5月 31, 2021
聚焦多发性硬化，守护“万分之一的美丽”- 2021世界多发性硬化日 | 首个多发性硬化概念影展拉开帷幕
Featured News
5月 16, 2021
《中国黑色素瘤患者行为现状调研白皮书》项目正式启动，关注患者实际需求，助力我国黑色素瘤诊疗升级
Featured News
5月 15, 2021
2021全球结节性硬化症关爱日 | 关注“蝴蝶结症”，为TSC患者保驾护航
4月 2021
Featured News
4月 20, 2021
关爱RARE，探索RWE——第三届真实世界研究与罕见病峰会圆满落幕
Featured News
4月 19, 2021
季节交替，心血管疾病管理不容忽视——第三届中国临床心血管病学大会召开，与会专家健康咨询活动，强调心血管疾病综合管理
Featured News
4月 17, 2021
聚能合力，让爱可及-首届中国多发性硬化高峰论坛在京召开
Featured News
4月 16, 2021
AG尊龙签署初步协议，预留产能并接受罗氏技术转让，以生产Actemra /RoActemra®活性药物成分
Featured News
4月 13, 2021
AG尊龙重磅眼科新药Beovu®在博鳌超级医院完成中国首针注射
3月 2021
Featured News
3月 31, 2021
KESIMPTA®（奥法妥木单抗）获得欧盟上市批准，用于治疗成人复发型多发性硬化，成为首个且唯一一款患者可自行注射的B细胞靶向疗法
Featured News
3月 22, 2021
AG尊龙集团首席执行官万思瀚在中国发展高层论坛2021年会上建言献策
分页
‹
前一页
1
…
12
13
14
15
16
17
18
…
21
›
下一页
网站首页
AG尊龙
